Vycor Medical, Inc. engages in the provision of innovative surgical and therapeutic solutions to the medical community. The company is headquartered in Boca Raton, Florida and currently employs 7 full-time employees. The company went IPO on 2009-03-31. The firm designs, develops and markets neurological medical devices and therapies. The firm operates two business units: Vycor Medical and NovaVision, both of which adopt a minimally or non-invasive approach. Vycor Medical designs, develops and markets medical devices for use in neurosurgery. NovaVision provides non-invasive rehabilitation therapies for those who have vision disorders resulting from neurological brain damage, such as that caused by a stroke. Vycor Medical’s ViewSite Brain Access System (VBAS) is a next-generation retraction and access system. VBAS is a minimally invasive neurosurgical device designed to improve access to brain lesions while reducing tissue damage and enhancing patient outcomes. The VBAS system is used in over 300 hospitals in the United States and in numerous countries internationally. NovaVision products include Visual Restoration Therapy (VRT) and NeuroEyeCoach.
Follow-Up Questions
Qui est le CEO de Vycor Medical Inc ?
Mr. Peter Zachariou est le Chief Executive Officer de Vycor Medical Inc, il a rejoint l'entreprise depuis 2010.
Quelle est la performance du prix de l'action VYCO ?
Le prix actuel de VYCO est de $0.175, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Vycor Medical Inc ?
Vycor Medical Inc appartient à l'industrie Health Care et le secteur est Health Care
Quelle est la capitalisation boursière de Vycor Medical Inc ?
La capitalisation boursière actuelle de Vycor Medical Inc est de $5.8M
